# Evaluation of the Implementation of the Pharmacogenetics and Personalized Medicine Program "MedeA" in the Extremadura Health Service.

> **NCT06607445** · — · RECRUITING · sponsor: **Complejo Hospitalario Universitario de Badajoz** · enrollment: 6445 (estimated)

## Conditions studied

- Adverse Drug Event

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06607445
- **Lead sponsor:** Complejo Hospitalario Universitario de Badajoz
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-05-26
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 6445 (ESTIMATED)
- **Last updated:** 2024-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06607445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06607445, "Evaluation of the Implementation of the Pharmacogenetics and Personalized Medicine Program "MedeA" in the Extremadura Health Service.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06607445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*